Diet induced mild hypercholesterolemia in pigs: Local and systemic inflammation, effects on vascular injury - Rescue by high-dose statin treatment

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Busnelli, Marco ^a   Manzini, Stefano ^a   Froio, Alberto ^a   Vargiolu, Alessia ^a   Cerrito, Maria Grazia ^a   Smolenski, Ryszard T ^a,b   Giunti, Massimo ^c   Cinti, Alessandro ^a   Zannoni, Augusta ^c   Leone, Biagio Eugenio ^a   Forni, Monica ^c   Bacci, Maria Laura ^c   Biasi, Giorgio Maria ^a   Giovannoni, Roberto ^a   Lavitrano, Marialuisa ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTES; ANIMALS; BIOPSY; CHOLESTEROL; CHOLESTEROL, LDL; DIET; DISEASE MODELS, ANIMAL; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERTROPHY; INFLAMMATION; LEUKOCYTE COUNT; LIVER; LUNG; LYMPHOCYTES; MACROPHAGES; MONOCYTES; SUBCUTANEOUS FAT, ABDOMINAL; SWINE; VASCULAR SYSTEM INJURIES;

EID: 84894078124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080588     Document Type: Article

References (42)

1. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444: 860-867. doi:10.1038/nature05485. PubMed: 17167474.
2. Busnelli M, Froio A, Bacci ML, Giunti M, Cerrito MG et al. (2009) Pathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigs. Atherosclerosis 207: 384-390. doi:10.1016/j. atherosclerosis.2009.05.022. PubMed: 19540496.
3. Tellez A, Krueger CG, Seifert P, Winsor-Hines D, Piedrahita C et al. (2010) Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointimal formation pattern similar to humans. Atherosclerosis 213: 518-524. doi:10.1016/j.atherosclerosis.2010.09.021. PubMed: 20950808.
4. Gregor MF, Hotamisligil GS (2011) Inflammatory Mechanisms in Obesity. Annu Rev Immunol 29: 415-445. doi:10.1146/annurev-immunol-031210-101322. PubMed: 21219177.
5. Lohmann C, Schäfer N, von Lukowicz T, Stein Sokrates, Borén J et al. (2009) Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. Atherosclerosis 207: 360-367. doi:10.1016/j.atherosclerosis.2009.05.004. PubMed: 19481752.
6. Subramanian S, Han CY, Chiba T, McMillen TS, Wang SA et al. (2008) Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28: 685-691. doi:10.1161/ATVBAHA.107.157685. PubMed: 18239153. (Pubitemid 351651333)
7. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783. doi: 10.1038/nri1937. PubMed: 16998510. (Pubitemid 44453463)
8. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97. doi: 10.1038/nri2921. PubMed: 21252989.
9. Stanton MC, Chen SC, Jackson JV, Rojas-Triana A, Kinsley D et al. (2011) Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm (Lond) 8: 8: 8-. doi:10.1186/1476-9255-8-8. PubMed: 21410952.
10. Wallace K, Burt AD, Wright MC (2008) Liver fibrosis. Biochem J 411: 1-18. doi:10.1042/BJ20071570. PubMed: 18333835. (Pubitemid 351482341)
11. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361. doi:10.1038/nature08938. PubMed: 20428172.
12. Li Y, Xu S, Jiang B, Cohen RA, Zang M (2013) Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs. PLOS ONE 8: e67532. doi:10.1371/journal. pone.0067532. PubMed: 23825667.
13. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H et al. (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48: 474-486. doi:10.1002/hep.22363. PubMed: 18666236.
14. Al-Shawwa B, Al-Huniti N, Titus G, Abu-Hasan M (2006) Hypercholesterolemia is a potential risk factor for asthma. J Asthma 43: 231-233. . doi:10.1080/02770900600567056 PubMed: 16754527 (Pubitemid 43879418)
15. Naura AS, Hans CP, Zerfaoui M, Errami Y, Ju J et al. (2009) High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors. Lab Invest 89: 1243-1251. doi:10.1038/labinvest.2009.98. PubMed: 19752857.
16. Heeba G, Moselhy ME, Hassan M, Khalifa M, Gryglewski R et al. (2009) Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. Br J Pharmacol 156: 1256-1266. doi:10.1111/j.1476-5381.2009.00125. x. PubMed: 19226281.
17. Ali F, Zakkar M, Karu K, Lidington EA, Hamdulay SS et al. (2009) Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem 284: 18882-18892. doi: 10.1074/jbc.M109.009886. PubMed: 19457866.
18. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V et al. (2006) Nitric oxide and atherosclerosis: an update. Nitric Oxidebiol Ch 15: 265-279. doi:10.1016/j.niox.2006.03.011. PubMed: 16684613. (Pubitemid 44649284)
19. Cerrito MG, Scagliarini A, Froio A, Liloia A, Busnelli M et al. (2011) Heme oxygenase-1 inhibition prevents intimal hyperplasia enhancing nitric oxide-dependent apoptosis of vascular smooth muscle cells. Biol Pharm Bull, 34: 1204-1214. doi:10.1248/bpb.34.1204. PubMed: 21804207.
20. Greenwood J, Steinman L, Zamvil SS (2006) Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 6: 358-370. doi:10.1038/nri1839. PubMed: 16639429.
21. Han KH, Ryu J, Hong KH, Ko J, Pak YK et al. (2005) HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation 111: 1439-1447. doi: 10.1161/01.CIR.0000158484.18024.1F. PubMed: 15781755. (Pubitemid 40396811)
22. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S et al. (2009) Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment. Am J Cardiol 104: 464-469. doi:10.1016/j.amjcard.2009.04.009. PubMed: 19660595.
23. Yoon SS, Dillon CF, Carroll M, Illoh K, Ostchega Y (2010) Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999-2004. J Atheroscler Thromb 17: 1176-1182. doi:10.5551/jat.5652. PubMed: 20805636.
24. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J et al. (2007) Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27: 1706-1721. doi:10.1161/ATVBAHA.107. 142570. PubMed: 17541027. (Pubitemid 47207165)
25. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA et al. (1999) Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 19: 2981-2992. doi: 10.1161/01.ATV.19.12.2981. PubMed: 10591679. (Pubitemid 30029828)
26. Schouten JA, Beynen AC, Hoitsma HF, Mulder C, Havekes LM et al. (1985) Serum lipoproteins in cholesterol-fed pigs after partial ileal bypass. Lab Anim 19: 98-105. doi:10.1258/002367785780942598. PubMed: 3999694. (Pubitemid 15105547)
27. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M (2004) Leukocytes and coronary heart disease. Atherosclerosis 172: 1-6. doi: 10.1016/S0021-9150(03) 00164-3. PubMed: 14709350. (Pubitemid 38058594)
28. Madjid M, Awan I, Willerson JT, Casscells SW (2004) Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44: 1945-1956. doi:10.1016/j.jacc.2004.07.056. PubMed: 15542275. (Pubitemid 39473277)
29. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A et al. (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117: 1649-1657. doi:10.1161/ CIRCULATIONAHA.107.745091. PubMed: 18347211. (Pubitemid 351482605)
30. Drechsler M, Megens RTA, van Zandvoort M, Weber C, Soehnlein O (2010) Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis. Circulation 122: 1837-1845. doi:10.1161/CIRCULATIONAHA.110.961714. PubMed: 20956207.
31. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW et al. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117: 195-205. doi:10.1172/JCI29950. PubMed: 17200719. (Pubitemid 46048466)
32. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M et al. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesitymediated insulin resistance. Arterioscler Thromb Vasc Biol 28: 1304-1310. doi:10.1161/ATVBAHA.108.165100. PubMed: 18420999.
33. Ohman MK, Shen Y, Obimba CI, Wright AP, Warnock M et al. (2008) Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117: 798-805. doi:10.1161/CIRCULATIONAHA.107. 717595. PubMed: 18212290. (Pubitemid 351640681)
34. Sultan A, Strodthoff D, Robertson AK, Paulsson-Berne G, Fauconnier J et al. (2009) T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice. Circ Res 104: 961-968. doi:10.1161/ CIRCRESAHA.108.190280. PubMed: 19299644.
35. Koruk M, Savaş MC, Yilmaz O, Tayşi S, Karakok M et al. (2003) Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 37: 177-182. doi: 10.1097/00004836-200308000-00017. PubMed: 12869892. (Pubitemid 36875582)
36. Lanthier N, Horsmans Y, Leclercq IA (2009) The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis. Curr Opin Clin Nutr Metab Care 12: 404-411. doi:10.1097/MCO.0b013e32832c7819. PubMed: 19474722.
37. Kainuma M, Fujimoto M, Sekiya N, Tsuneyama K, Cheng C et al. (2006) Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis. J Gastroenterol 41: 971-980. doi:10.1007/s00535-006-1883-1. PubMed: 17096066. (Pubitemid 44741410)
38. Tous M, Ferré N, Rull A, Marsillach J, Coll B et al. (2006) Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun 340: 1078-1084. doi:10.1016/j.bbrc.2005.12.109. PubMed: 16403442. (Pubitemid 43083388)
39. Dimitrova Y, Dunoyer-Geindre S, Reber G, Mach F, Kruithof EKO et al. (2003) Effects of statins on adhesion molecule expression in endothelial cells. J Thromb Haemost 1: 2290-2299. doi:10.1046/j.1538-7836.2003.00412.x. PubMed: 14629460.
40. Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR et al. (2003) Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc Res 59: 755-766. doi:10.1016/S0008-6363(03)00515-7. PubMed: 14499877. (Pubitemid 38368692)
41. Della-Morte D, Moussa I, Elkind MS, Sacco RL, Rundek T (2011) The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res 33: 991-994: 991-4. doi:10.1179/1743132811Y.0000000039. PubMed: 22081003.
42. Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Gerasimidis T et al. (2010) Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J Vasc Surg 51: 114-121. doi:10.1016/j.jvs.2009.07.119. PubMed: 19837545.